Poop pills from different donors: a new hope for ulcerative colitis?

NCT ID NCT06591013

Completed Disease control Sponsor: First Affiliated Hospital of Kunming Medical University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 3 times

Summary

This study tested fecal microbiota transplantation (FMT) from different donors to treat ulcerative colitis, a type of inflammatory bowel disease. Researchers gave 102 patients a one-time colonoscopic infusion of fresh fecal bacteria from healthy donors. The goal was to see if donor differences affect remission rates and gut health, offering a potential new treatment option for those who stop responding to standard therapies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fecal microbiota transplantation (FMT)
What this could lead to: If successful, this could point toward a more effective, donor-matched FMT approach for managing ulcerative colitis and reducing symptoms.
What could go wrong: This is a completed early-stage study with 102 participants, so results may not apply to everyone. FMT carries risks like infection or worsening of symptoms, and long-term benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFLAMMATORY BOWEL DISEASES

Contacts and locations

Locations

China

Kunming, Yunnan, 650032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.